• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Edgewise

Edgewise Therapeutics

A Movement in Muscle

  • Clinical Trials
  • Careers
  • Investors & News
  • Company
    • Company Overview
    • Leadership Team
    • Careers
    • Contact Us

    We are dedicated to transforming cardiovascular muscle diseases.

    Learn More

  • Science
    • Pipeline
    • EDG-7500
    • EDG-15400
    • Clinical Trials
    • Posters & Presentations

    All of us at Edgewise are committed to developing new medicines for people facing serious cardiovascular diseases with unmet medical needs.

    Explore our Pipeline

  • Disease Areas
    • Cardiovascular Diseases
    • Muscular Dystrophy & Sevasemten

    Servier Acquires Our Muscular Dystrophy Program

    Following the close of our transaction with Servier, Edgewise’s muscular dystrophy business, including sevasemten, is now part of Servier. Servier’s global capabilities and commitment to neuromuscular diseases position it to advance sevasemten and continue supporting the patient and advocacy communities we have been privileged to serve.

    Edgewise is now focused exclusively on advancing high-impact therapies for people living with serious cardiovascular diseases.

    Learn more

  • Patients & Families
  • Investors & News
    • Corporate Profile
    • News
    • Events & Presentations
    • Analyst Coverage
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts
HomeCompany

Company

We are Dedicated to transforming cardiovascular diseases

At Edgewise, we appreciate the life-limiting impact of serious cardiovascular diseases. We are committed to helping people and families living with them by pursuing a new era of muscle-focused medicines with patients at the center.

Cardiac muscle diseases require a unique mindset

That’s why we built Edgewise differently. We seek to pursue lines of scientific inquiry around muscle pathology, starting with the patient need, that are unique, powerful, and elegant. We commit ourselves to asking new questions and finding new therapeutic answers for cardiovascular diseases with life-limiting impact. We chose Boulder, Colorado, for our headquarters, establishing an entirely new life science nexus that encourages creative thinking, sound science, and capitalizes on the vast talent the state and nearby institutions have to offer.

We follow the science

Muscle biology is integral and complex. Every day, we follow science where it leads us to bring the vast potential of cardiovascular-targeted therapeutics to the lives of those who need it most. Our way of working starts with the patient and their unmet need then we look to science to solve the problem for the communities we serve.

Patients are at the core
of our mission

We recognize that for people and families facing serious cardiovascular diseases, every day without effective medicine is a day too late. This urgency is what drives us to think harder, dig deeper, and continue pursuing what we believe are potentially life-changing medicines that help preserve and protect muscle function.

Join us

Meet our leadership team

Explore the backgrounds and expertise of our executive leadership.

Leadership team

Our
values

Our ability to succeed depends on a cross-functional team embracing our core values.

Connection

We connect with patients and families to better understand their experience and needs which help guide our plans. We connect with our team to foster our unique skills and abilities. We treat each other with respect and embrace diversity.

Excellence

We are intensely focused on our mission to invent medicines that truly make a difference for patients. We excel within our core competencies and understand the value our role brings to the team. We leverage the collective knowledge and skills of our team and external experts to achieve our goals.

Courage

We are charting a new course. We learn from the patients we serve – their tenacity and courage fuel our passion. We are driven by their urgent need for innovative therapies. We support final decisions and move forward as a team. We celebrate successes, embrace failures and continuously learn.

Add muscle to your career

If you’re driven to be a part of developing the next generation of cardiovascular medicines, learn more about what it’s like to work with us.

Learn more about careers at Edgewise

Footer

Edgewise Therapeutics
  • Company
  • Science
  • Disease Areas
  • Patients & Families
  • Investors & News

In the Clinic

We are advancing novel precision therapeutics for serious cardiovascular disease.

Explore our pipeline

2026 © Copyright. Edgewise Therapeutics. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
Facebook X, formally Twitter LinkedIn Instagram YouTube
logo
  • Company
    • Leadership Team
    • Careers
    • Contact Us
  • Science
    • Pipeline
    • EDG-7500
    • EDG-15400
    • Clinical Trials
    • Posters & Presentations
  • Disease Areas
    • Cardiovascular Diseases
    • Muscular Dystrophy & Sevasemten
  • Patients & Families
  • Investors & Media
    • Corporate Profile
    • News
    • Events & Presentations
    • Analyst Coverage
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
    • Financials
      • Quarterly Results
      • SEC Filings
    • Goverance
      • Governance Documents
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts